Schubert & CO Medpace Holdings, Inc. Transaction History

Schubert & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$174.31 - $239.52 $348 - $479	-2 Reduced 8.33%	22 $4,000
Q4 2022 Jan 31, 2023	BUY	$153.06 - $226.57 $918 - $1,359	6 Added 33.33%	24 $5,000
Q3 2022 Oct 21, 2022	BUY	$145.13 - $182.49 $580 - $729	4 Added 28.57%	18 $3,000
Q2 2022 Aug 01, 2022	BUY	$130.2 - $168.03 $1,041 - $1,344	8 Added 133.33%	14 $2,000
Q1 2022 May 16, 2022	BUY	$138.87 - $214.31 $138 - $214	1 Added 20.0%	6 $1,000
Q4 2021 Jan 28, 2022	BUY	$182.74 - $227.9 $913 - $1,139	5 New	5 $1,000

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.